Literature DB >> 30918961

Targeted copy number analysis outperforms histologic grading in predicting patient survival for WHO grades II/III IDH-mutant astrocytomas.

Patrick J Cimino1, Eric C Holland2.   

Abstract

Entities:  

Keywords:  IDH; astrocytoma; biomarkers; isocitrate dehydrogenase; molecular profiling

Mesh：

Substances：

Year:  2019        PMID： 30918961      PMCID： PMC6556841          DOI： 10.1093/neuonc/noz052

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  6 in total

1.  Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.

Authors:  Mitsuaki Shirahata; Takahiro Ono; Damian Stichel; Daniel Schrimpf; David E Reuss; Felix Sahm; Christian Koelsche; Annika Wefers; Annekathrin Reinhardt; Kristin Huang; Philipp Sievers; Hiroaki Shimizu; Hiroshi Nanjo; Yusuke Kobayashi; Yohei Miyake; Tomonari Suzuki; Jun-Ichi Adachi; Kazuhiko Mishima; Atsushi Sasaki; Ryo Nishikawa; Melanie Bewerunge-Hudler; Marina Ryzhova; Oksana Absalyamova; Andrey Golanov; Peter Sinn; Michael Platten; Christine Jungk; Frank Winkler; Antje Wick; Daniel Hänggi; Andreas Unterberg; Stefan M Pfister; David T W Jones; Martin van den Bent; Monika Hegi; Pim French; Brigitta G Baumert; Roger Stupp; Thierry Gorlia; Michael Weller; David Capper; Andrey Korshunov; Christel Herold-Mende; Wolfgang Wick; David N Louis; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2018-04-23       Impact factor: 17.088

2.  Copy number profiling across glioblastoma populations has implications for clinical trial design.

Authors:  Patrick J Cimino; Lisa McFerrin; Hans-Georg Wirsching; Sonali Arora; Hamid Bolouri; Raul Rabadan; Michael Weller; Eric C Holland
Journal:  Neuro Oncol       Date:  2018-09-03       Impact factor: 12.300

3.  IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.

Authors:  Adriana Olar; Khalida M Wani; Kristin D Alfaro-Munoz; Lindsey E Heathcock; Hinke F van Thuijl; Mark R Gilbert; Terri S Armstrong; Erik P Sulman; Daniel P Cahill; Elizabeth Vera-Bolanos; Ying Yuan; Jaap C Reijneveld; Bauke Ylstra; Pieter Wesseling; Kenneth D Aldape
Journal:  Acta Neuropathol       Date:  2015-02-21       Impact factor: 17.088

Review 4.  Grading of Diffuse Astrocytic Gliomas: A Review of Studies Before and After the Advent of IDH Testing.

Authors:  Andreas von Deimling; Takahiro Ono; Mitsuaki Shirahata; David N Louis
Journal:  Semin Neurol       Date:  2018-03-16       Impact factor: 3.420

5.  Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.

Authors:  Patrick J Cimino; Michael Zager; Lisa McFerrin; Hans-Georg Wirsching; Hamid Bolouri; Bettina Hentschel; Andreas von Deimling; David Jones; Guido Reifenberger; Michael Weller; Eric C Holland
Journal:  Acta Neuropathol Commun       Date:  2017-05-22       Impact factor: 7.801

6.  DNA methylation-based classification of central nervous system tumours.

Authors:  David Capper; David T W Jones; Martin Sill; Volker Hovestadt; Daniel Schrimpf; Dominik Sturm; Christian Koelsche; Felix Sahm; Lukas Chavez; David E Reuss; Annekathrin Kratz; Annika K Wefers; Kristin Huang; Kristian W Pajtler; Leonille Schweizer; Damian Stichel; Adriana Olar; Nils W Engel; Kerstin Lindenberg; Patrick N Harter; Anne K Braczynski; Karl H Plate; Hildegard Dohmen; Boyan K Garvalov; Roland Coras; Annett Hölsken; Ekkehard Hewer; Melanie Bewerunge-Hudler; Matthias Schick; Roger Fischer; Rudi Beschorner; Jens Schittenhelm; Ori Staszewski; Khalida Wani; Pascale Varlet; Melanie Pages; Petra Temming; Dietmar Lohmann; Florian Selt; Hendrik Witt; Till Milde; Olaf Witt; Eleonora Aronica; Felice Giangaspero; Elisabeth Rushing; Wolfram Scheurlen; Christoph Geisenberger; Fausto J Rodriguez; Albert Becker; Matthias Preusser; Christine Haberler; Rolf Bjerkvig; Jane Cryan; Michael Farrell; Martina Deckert; Jürgen Hench; Stephan Frank; Jonathan Serrano; Kasthuri Kannan; Aristotelis Tsirigos; Wolfgang Brück; Silvia Hofer; Stefanie Brehmer; Marcel Seiz-Rosenhagen; Daniel Hänggi; Volkmar Hans; Stephanie Rozsnoki; Jordan R Hansford; Patricia Kohlhof; Bjarne W Kristensen; Matt Lechner; Beatriz Lopes; Christian Mawrin; Ralf Ketter; Andreas Kulozik; Ziad Khatib; Frank Heppner; Arend Koch; Anne Jouvet; Catherine Keohane; Helmut Mühleisen; Wolf Mueller; Ute Pohl; Marco Prinz; Axel Benner; Marc Zapatka; Nicholas G Gottardo; Pablo Hernáiz Driever; Christof M Kramm; Hermann L Müller; Stefan Rutkowski; Katja von Hoff; Michael C Frühwald; Astrid Gnekow; Gudrun Fleischhack; Stephan Tippelt; Gabriele Calaminus; Camelia-Maria Monoranu; Arie Perry; Chris Jones; Thomas S Jacques; Bernhard Radlwimmer; Marco Gessi; Torsten Pietsch; Johannes Schramm; Gabriele Schackert; Manfred Westphal; Guido Reifenberger; Pieter Wesseling; Michael Weller; Vincent Peter Collins; Ingmar Blümcke; Martin Bendszus; Jürgen Debus; Annie Huang; Nada Jabado; Paul A Northcott; Werner Paulus; Amar Gajjar; Giles W Robinson; Michael D Taylor; Zane Jaunmuktane; Marina Ryzhova; Michael Platten; Andreas Unterberg; Wolfgang Wick; Matthias A Karajannis; Michel Mittelbronn; Till Acker; Christian Hartmann; Kenneth Aldape; Ulrich Schüller; Rolf Buslei; Peter Lichter; Marcel Kool; Christel Herold-Mende; David W Ellison; Martin Hasselblatt; Matija Snuderl; Sebastian Brandner; Andrey Korshunov; Andreas von Deimling; Stefan M Pfister
Journal:  Nature       Date:  2018-03-14       Impact factor: 49.962
  6 in total
  10 in total

Review 1.  Molecular Aberrations Stratify Grade 2 Astrocytomas Into Several Rare Entities: Prognostic and Therapeutic Implications.

Authors:  Valeria Internò; Giacomo Triggiano; Pierluigi De Santis; Luigia Stefania Stucci; Marco Tucci; Camillo Porta
Journal:  Front Oncol       Date:  2022-06-10       Impact factor: 5.738

Review 2.  Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System.

Authors:  Takashi Komori
Journal:  Lab Invest       Date:  2021-09-09       Impact factor: 5.662

3.  IDH-mutant gliomas with additional class-defining molecular events.

Authors:  Jared T Ahrendsen; Matthew Torre; David M Meredith; Jason L Hornick; David A Reardon; Patrick Y Wen; Kee K Yeo; Seth Malinowski; Keith L Ligon; Shakti Ramkissoon; Sanda Alexandrescu
Journal:  Mod Pathol       Date:  2021-03-26       Impact factor: 8.209

4.  A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy.

Authors:  Joachim P Steinbach; Patrick N Harter; Oliver Bähr; Eike Steidl; Katharina Filipski; Pia S Zeiner; Marlies Wagner; Emmanouil Fokas; Marie-Therese Forster; Michael W Ronellenfitsch; Iris Divé
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-04       Impact factor: 4.553

5.  WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas.

Authors:  Louise Carstam; Alba Corell; Anja Smits; Anna Dénes; Hanna Barchéus; Klara Modin; Helene Sjögren; Sandra Ferreyra Vega; Thomas Olsson Bontell; Helena Carén; Asgeir Store Jakola
Journal:  Front Oncol       Date:  2022-01-10       Impact factor: 6.244

6.  Machine learning modeling of genome-wide copy number alteration signatures reliably predicts IDH mutational status in adult diffuse glioma.

Authors:  Nicholas Nuechterlein; Linda G Shapiro; Eric C Holland; Patrick J Cimino
Journal:  Acta Neuropathol Commun       Date:  2021-12-04       Impact factor: 7.578

7.  Molecular landscape of IDH-mutant astrocytoma and oligodendroglioma grade 2 indicate tumor purity as an underlying genomic factor.

Authors:  Yu Wang; Wenbin Ma; Binghao Zhao; Yu Xia; Fengchun Yang; Yaning Wang; Yuekun Wang; Yadong Wang; Congxin Dai
Journal:  Mol Med       Date:  2022-03-14       Impact factor: 6.354

8.  CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.

Authors:  Romain Appay; Caroline Dehais; Claude-Alain Maurage; Agusti Alentorn; Catherine Carpentier; Carole Colin; François Ducray; Fabienne Escande; Ahmed Idbaih; Aurélie Kamoun; Yannick Marie; Karima Mokhtari; Emeline Tabouret; Nesrine Trabelsi; Emmanuelle Uro-Coste; Jean-Yves Delattre; Dominique Figarella-Branger
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 13.029

9.  Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.

Authors:  Queenie Hoi-Wing Wong; Kay Ka-Wai Li; Wei-Wei Wang; Tathiane M Malta; Houtan Noushmehr; Yura Grabovska; Chris Jones; Aden Ka-Yin Chan; Johnny Sheung-Him Kwan; Queenie Jun-Qi Huang; Gabriel Chun-Hei Wong; Wen-Cai Li; Xian-Zhi Liu; Hong Chen; Danny Tat-Ming Chan; Ying Mao; Zhen-Yu Zhang; Zhi-Feng Shi; Ho-Keung Ng
Journal:  Mod Pathol       Date:  2021-03-10       Impact factor: 8.209

10.  Homozygous deletion of CDKN2A by fluorescence in situ hybridization is prognostic in grade 4, but not grade 2 or 3, IDH-mutant astrocytomas.

Authors:  Daniel F Marker; Thomas M Pearce
Journal:  Acta Neuropathol Commun       Date:  2020-10-20       Impact factor: 7.801
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.